Warning letter
CFH Laboratories LP: warning letter of Nov 13, 2001
FDA warning letter UCM178627 · New Jersey District Office
Key facts
| Reference number | UCM178627 |
|---|---|
| Company | CFH Laboratories LP |
| Subject | Quality System Regulations for Medical Devices/Enzymatic Tablets |
| Issue date | Nov 13, 2001 |
| Posted date | Nov 13, 2001 |
| Issuing office | New Jersey District Office |
| Product type | Devices |
| CFR sections cited | 820 |
| Country | 3 |
| Inspection city | Morris Plains |
| Inspection ZIP | 07950-2443 |
| Inspection start date | Sep 4, 2001 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: